Our Biomarker team offers the drug discovery community targeted and bespoke solutions that use highly multiplexed measurement technologies. Combined with expert industry-experienced scientists, we present insightful answers to advance therapeutic opportunities through development. Whatever your challenge we will work with you to develop a bespoke solution. Learn more: https://hubs.li/Q02y4GNQ0 #Biomarkers #LifeSciences
Medicines Discovery Catapult
Biotechnology
Alderley, Cheshire 13,198 followers
Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery.
About us
We collaborate with UK medicines discovery and diagnostics organisations, giving them access to industry-leading expertise, cutting-edge technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have.
- Website
- https://md.catapult.org.uk
External link for Medicines Discovery Catapult
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Alderley, Cheshire
- Type
- Nonprofit
- Founded
- 2016
- Specialties
- biotechnology, pharma, medicines discovery, biotech, informatics, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, and drug research
Locations
- Primary
Get directions
Alderley Park
Alderley, Cheshire SK104ZF, GB
Employees at Medicines Discovery Catapult
-
Paul Beastall
Board chair, NED and advisor - deep tech that can change the world
-
Alistair Macdonald
CEO, Non-Executive Director and Consultant
-
Samrina Rehman, PhD
Systems Biologist | Bioinformatics Data Scientist | Executive MBA Candidate
-
Christopher Southan
Competitive Intelligence Analyst, Informatics, Medicines Discovery Catapult
Updates
-
📊 State of the Discovery Nation report reveals the extent of the sector's perfect storm. 📰 Read the article and download the report in our latest newsletter 👇 Medicines Discovery Catapult BioIndustry Association (BIA) The Association of the British Pharmaceutical Industry (ABPI) #SMEsupport #LifeSciences #DrugDiscovery #SoDN2024 #Report
-
Our cutting-edge biomarker platform has a suite of high-tech multi-omic technologies revolutionising biomarker discovery and validation. 🔗 Unlock the potential of your projects: https://hubs.li/Q02xtMP70 #Biomarkers #DrugDiscovery
-
Medicines Discovery Catapult reposted this
Our next panel will be discussing essential #Skills for building a lean strong #Biotech start-up 💪 📌 Dr Kate Barclay, Skills Strategy Consultant, BioIndustry Association (BIA) 📌 Marc Daigneault, Venture Building Lead, Medicines Discovery Catapult 📌 Martin M., Deputy Director, Business Growth, Innovate UK 📌 Ioanna Mylonaki - MBA, PhD, Preclinical R&D lead, Sixfold Bioscience Thank you to our event sponsors eLabNext, HSBC Innovation Banking, Johnson & Johnson, Kadans Science Partner, Kilburn & Strode, Sartorius, Osborne Clarke - UK, CMS UK and RRxCo.™. 👏 #BiotechStartups
-
Earlier this year, Medicines Discovery Catapult and Seda Pharmaceutical Development Services collaborated to make and test #LipidNanoparticles using single molecule localisation #microscopy. 🔗 Read the full report of their findings: https://hubs.li/Q02xk23X0 #LifeSciences #Collaboration #Nanoparticles #RNAtherapeutics
-
📅 Event: 16 May 📢 BioIndustry Association (BIA) Start-up Festival 2024 📍Glaziers Hall, London Tomorrow, our Venture Building Lead Marc Daigneault will be one of the speakers at the annual BIA Start-up Festival 2024 in London. The event will bring together the best of rising talent in the sector for a day of informative sessions designed to build on your existing knowledge and allow you to learn from peers and established industry experts alike. 🕛 12:00 - 12:45: Marc Daigneault will be participating in Panel 2: 'Building Skills within a Lean Team’ 🔗 Learn more and register here: https://hubs.li/Q02x4rQc0 #BIA # StartUpFestival2024 #Event #StartUps
-
📢 Last week, we launched the State of the Discovery Nation 2024 report, in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry. Download here: https://hubs.li/Q02x3D3L0 The State of the Discovery Nation 2024 examines the sector’s challenges. It shows what is needed to secure a rich medicines pipeline and build on the UK’s global leadership in #LifeSciences. This includes: ---▶️ Creating strong partnerships with translational experts, who can take early-stage discoveries through to late-stage clinical development so #SMEs can de-risk assets for investment wherever they are in the UK ---▶️ Providing high-quality #laboratory facilities and incubator spaces for companies at all stages of maturity ---▶️ Make funds available, visible and accessible to support SMEs. Leverage private/public initiatives to co-develop pipelines of high-quality #FitToFund companies. In partnership with: Medicines Discovery Catapult | BioIndustry Association (BIA) | The Association of the British Pharmaceutical Industry (ABPI) #DrugDiscovery #SoDN2024 #Collaboration #SME
-
Exciting news from one of our partners, PlaqueTec Ltd., today. #Collaboration opens new opportunities for precision medicine in #HeartDisease. In February 2022, PlaqueTec was awarded Innovate UK Business Growth funding to collaborate with Medicines Discovery Catapult on a pilot project aimed at identifying #NovelDrugTargets in coronary artery disease.
🤝🏻 We have successfully completed our collaboration with the Welch research group at The Babraham Institute to evaluate lead compounds predicted to bind a pro-inflammatory protein identified in our pilot studies. The project was funded by the UKRI-BBSRC Campus Innovation Award (CIA), via the Babraham Research Campus Collaboration Fund in October 2023. The collaboration demonstrates that new disease-specific targets identified in our trial have the potential to be modifiable by small molecule drugs—opening new opportunities for a precision medicine approach to heart disease. We are now evaluating the target in our ongoing BIOPATTERN trial and, if validated, further development will be pursued. Read more ➡ https://rb.gy/6b1o61 #CoronaryArteryDisease #Collaboration #ClinicalTrial #PrecisionMedicine #HeartDisease
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
plaquetec.com
-
📅 Event: 21 May 📢 North West Health Cluster Anniversary Conference 📍 UKRI-STFC Daresbury Laboratory Atrium, ci-Tech Daresbury Campus (WA4 4AD) Join us next week for the North West Health Cluster Anniversary Conference event at Daresbury Laboratory. Our Strategy Leader - Medicines Discovery Ecosystems Sally-Ann Emmas, Head of Biomarkers Gayle Marshall and Head of Translational Imaging Dr Juliana Maynard will be attending. 🕦 11:30 - 12:50: Sally-Ann will be participating at the session 'How do we Support the Research and Innovation System to Thrive in 2040' 🕑 14:15 - 16:00: Juliana and Gayle are taking part in the panel 'Advanced Therapies and Accelerating Translation'. This event focuses on #CancerResearch and Innovation, from discussions on health inequalities to how research and innovation can close the gap, this event will showcase developments in advanced therapies and advanced compute. 🔗 Learn more and register for this free event: https://lnkd.in/gNZKcTfG STFC Business & Innovation | Northern Health Science Alliance Ltd | Medicines Discovery Catapult | North West Cancer Research | The Institute of Cancer Research | Health Innovation North West Coast #NWHealthCluster #AdvancedTherapies #AdvancedCompute
-
Medicines Discovery Catapult reposted this
NEWS: New #MedicinesDiscoveryCatapult report concludes that inflation and geopolitical instability are having a deep impact on SMEs that drive #drugdiscovery and innovation in the UK’s #lifesciences sector. https://lnkd.in/efz73Ba4
Report warns economic instability has hit UK drug discovery
pharmaphorum.com